ImmunoScape inks agreement with Cue Biopharma to launch next-gen cancer immunotherapy
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Diversifying its portfolio to include late-phase antiviral agent
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Subscribe To Our Newsletter & Stay Updated